The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

An mRNA medicine is a synthetic mRNA, a piece of genetic information, that we introduce into the cell in combination with a ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Specific DOPE-Cx derivatives, such as DOPE-C8, demonstrated significantly higher mRNA expression levels in the liver ... delivery systems but also opens new avenues for the rational design of ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...